---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-002274"
form_type: "8-K"
ticker: "MEDP"
cik: "0001668397"
company_name: "Medpace Holdings, Inc."
filed_at: "2021-10-25T23:59:59+00:00"
generated_at: "2026-06-28T18:28:45.011736+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Medpace Q3 revenue $295.6M (+28.3%), EPS $1.29; net new awards $408M

## Summary
- Revenue $295.6M, up 28.3% YoY; net income $48.6M ($1.29 diluted EPS) vs $41.5M ($1.09) prior year.
- Net new business awards $408M, up 29.4%, book-to-bill 1.38x; backlog $1.8B (+29%).
- EBITDA $60.1M (20.3% margin) vs $51.9M (22.5%) prior year; net income margin 16.4% vs 18%.
- Constant currency organic revenue growth 28.1%.

## SEC filing metadata
- accession: 0000950170-21-002274
- form_type: 8-K
- ticker: MEDP
- cik: 0001668397
- company_name: Medpace Holdings, Inc.
- filed_at: 2021-10-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1668397/000095017021002274/0000950170-21-002274-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1668397/000095017021002274/medp-20211025.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-002274
- JSON: https://secwatch.observer/filing/0000950170-21-002274.json
- Plain text: https://secwatch.observer/filing/0000950170-21-002274.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.